SunTrust Starts Supernus Pharmaceuticals (SUPN) at Buy
Tweet
Share
E-mailGet Alerts SUPN Hot Sheet
Price: $44.08 +0.11%
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Rating Summary:
9 Buy, 3 Hold, 0 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 5 | Down: 17 | New: 22
Join SI Premium – FREE
SunTrust Robinson Humphrey initiated coverage on Supernus Pharmaceuticals (NASDAQ: SUPN) with a Buy rating and a price target of $30.00.
For an analyst ratings summary and ratings history on Supernus Pharmaceuticals click here. For more ratings news on Supernus Pharmaceuticals click here.
Shares of Supernus Pharmaceuticals closed at $16.23 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Truist Securities Starts Vishay Intertechnology (VSH) at Buy
- Supernus Pharmaceuticals to Participate in September Investor Conferences
- Rosenblatt Assumes Broadcom Limited (AVGO) at Buy
Create E-mail Alert Related Categories
Hot New Coverage, New CoverageRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
